Subscribe to RSS
DOI: 10.1055/a-2500-0185
Recommendations of the AGG (Obstetrics and Prenatal Medicine Working Group, Section Maternal Diseases) on Maternal Thrombocytopenia in Pregnancy
Article in several languages: English | deutsch
Abstract
Thrombocytopenia is a common hematologic disorder characterized by reduced platelet count in peripheral blood. Acquired and chronic thrombocytopenia is very important in obstetrics. A decreased platelet count of 15–20% is normal in uncomplicated pregnancies; platelet count decreases continuously from 1st trimester on, however usually remains within the normal ranges of between 150 and 450 G/L. The occurrence of mild thrombocytopenia (100–149 G/L) in pregnancy is usually due to gestational thrombocytopenia and does not require further evaluation. But a differential diagnostic examination should be carried out if the platelet count drops to < 100 G/L. Other forms of thrombocytopenia may also occur or become activated in pregnancy and they require special attention. This recommendation presents the diagnostic workup, differential diagnoses, and possible consequences of different thrombocytopenia conditions in pregnancy. The recommendations are based on current international recommendations (George 2023, Bussel 2023) and a search of the literature using the search terms “thrombocytopenia” and “pregnancy”.
Publication History
Received: 21 October 2024
Accepted after revision: 07 December 2024
Article published online:
11 March 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References/Literatur
- 1 Reese JA, Peck JD, Deschamps DR. et al. Platelet Counts during Pregnancy. N Engl J Med 2018; 379: 32-43
- 2 McIntosh JJ, Perez Botero J. Thrombocytopenia in pregnancy. In: Leung LLK, Lockwood CJ. , ed. UpToDate.com. 2023. Accessed January 02, 2024 at: https://www.uptodate.com/contents/thrombocytopenia-in-pregnancy
- 3 Bussel JB, Hou M, Cines DB. Management of Primary Immune Thrombocytopenia in Pregnancy. N Engl J Med 2023; 389: 540-548
- 4 ACOG Practice Bulletin No. 207: Thrombocytopenia in Pregnancy. Obstet Gynecol 2019; 133: e181-e193
- 5 Pishko AM, Levine LD, Cines DB. Thrombocytopenia in pregnancy: Diagnosis and approach to management. Blood Rev 2020; 40: 100638
- 6 Reese JA, Peck JD, Yu Z. et al. Platelet sequestration and consumption in the placental intervillous space contribute to lower platelet counts during pregnancy. Am J Hematol 2019; 94: E8-E11
- 7 Fogerty AE, Dzik W. Gestational thrombocytopenia: a case-control study of over 3,500 pregnancies. Br J Haematol 2021; 194: 433-438
- 8 Provan D, Arnold DM, Bussel JB. et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 2019; 3: 3780-3817
- 9 Rodeghiero F, Marranconi E. Management of immune thrombocytopenia in women: current standards and special considerations. Expert Rev Hematol 2020; 13: 175-185
- 10 Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993; 329: 1463-1466
- 11 Gonzalez-Porras JR, Palomino D, Vaquero-Roncero LM. et al. Bleeding Complications Associated with Pregnancy with Primary Immune Thrombocytopenia: A Meta-Analysis. TH Open 2022; 6: e230-e237
- 12 Eslick R, McLintock C. Managing ITP and thrombocytopenia in pregnancy. Platelets 2020; 31: 300-306
- 13 Stam W, Wachholz GE, de Pereda JM. et al. Fetal and neonatal alloimmune thrombocytopenia: Current pathophysiological insights and perspectives for future diagnostics and treatment. Blood Rev 2023; 59: 101038
- 14 Martí-Carvajal AJ, Peña-Martí GE, Comunián-Carrasco G. Medical treatments for idiopathic thrombocytopenic purpura during pregnancy. Cochrane Database Syst Rev 2009; 2009 (04) CD007722
- 15 Sun D, Shehata N, Ye XY. et al. Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy. Blood 2016; 128: 1329-1335
- 16 Neunert C, Terrell DR, Arnold DM. et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv 2019; 3: 3829-3866
- 17 Rottenstreich A, Dor S, Keren-Politansky A. et al. Pregnancy and non-pregnancy related immune thrombotic thrombocytopenic purpura in women of reproductive age. J Thromb Thrombolysis 2021; 51: 187-193
- 18 Asmis LM, Serra A, Krafft A. et al. Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic Purpura. N Engl J Med 2022; 387: 2356-2361
- 19 Perez Botero J, Reese JA, George JN. et al. Severe thrombocytopenia and microangiopathic hemolytic anemia in pregnancy: A guide for the consulting hematologist. Am J Hematol 2021; 96: 1655-1665
- 20 AWMF. S2k-Leitlinie Hypertensive Erkrankungen in der Schwangerschaft (HES): Diagnostik und Therapie. Accessed July 17, 2024 at: https://register.awmf.org/de/leitlinien/detail/015-018
- 21 Rath W, Tsikouras P, Stelzl P. HELLP Syndrome or Acute Fatty Liver of Pregnancy: A Differential Diagnostic Challenge: Common Features and Differences. Geburtshilfe Frauenheilkd 2020; 80: 499-507
- 22 Jiang Y, Cheng Y, Ma S. et al. Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment. J Autoimmun 2022; 132: 102887
- 23 Kuschel B, Schäfer-Graf UM, Schmidt M. AGG – Section Maternal Diseases in Pregnancy. et al. Management of Rheumatic Diseases During Pregnancy and Breastfeeding: Position Paper of the Working Group for Obstetrics and Prenatal Medicine in the German Society for Gynecology and Obstetrics e. V. (AGG – Section Maternal Diseases in Pregnancy). Geburtshilfe Frauenheilkd 2024; 84: 130-143